BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Paradigms Foundation - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://paradigms.foundation
X-WR-CALDESC:Events for Paradigms Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261123T170000
DTEND;TZID=Europe/Paris:20261123T181500
DTSTAMP:20261020T144017Z
CREATED:20260804T090238Z
LAST-MODIFIED:20261020T144017Z
UID:14645-1795453200-1795457700@paradigms.foundation
SUMMARY:Live Webinar: A Biosimilar in Multiple Sclerosis Care in Belgium: Evidence\, Confidence and Implementation
DESCRIPTION:Live webinar | Online \n\n\n\nJoin a 75-minute expert-led webinar examining the clinical\, regulatory and practical considerations involved in introducing a biosimilar into Multiple Sclerosis (MS) care in Belgium. \n\n\n\nThe programme will combine Belgian healthcare perspectives with experience from France and practical insights into MS-centre workflows. Participants will also have the opportunity to discuss implementation questions during an extended panel discussion and Q&A. \n\n\n\n\nRegister for the live webinar\n\n\n\n\nAbout the webinar\n\n\n\nWith the expected introduction of a biosimilar treatment option in Belgian MS care\, neurologists need clear and independent education on how biosimilars are assessed\, approved and implemented. \n\n\n\nThis webinar will address the regulatory principles and clinical evidence supporting biosimilars\, including how they differ from generics. It will also consider how international experience may inform decision-making in Belgium. \n\n\n\nThe faculty will discuss practical implementation in daily MS care\, including communication with people living with MS\, shared decision-making\, infusion-centre pathways\, multidisciplinary coordination and monitoring procedures. \n\n\n\nLearning objectives\n\n\n\nBy the end of the webinar\, participants will be able to: \n\n\n\n\nExplain the regulatory framework for biosimilars and how biosimilars differ from generics.\n\n\n\nRelate experience from the introduction of a biosimilar in France to the Belgian context.\n\n\n\nDiscuss practical approaches to patient communication\, infusion pathways and monitoring when implementing biosimilars in MS care.\n\n\n\nSupport informed discussion about biosimilars with multidisciplinary care teams and people living with Multiple Sclerosis.\n\n\n\nConsider the practical implications of biosimilar implementation for MS-centre workflows.\n\n\n\n\nWho should attend?\n\n\n\nThis webinar is intended for: \n\n\n\n\nClinically active neurologists based in Belgium\n\n\n\nMultiple Sclerosis specialists\n\n\n\nNeurology residents and trainees\n\n\n\nMS nurses and other healthcare professionals involved in multidisciplinary MS care\n\n\n\n\nThe webinar will be submitted for accreditation to the relevant Belgian authorities. \n\n\n\nRecording\n\n\n\nThe webinar recording is expected to be published on the ParadigMS educational platform following the live session. Access will be restricted to healthcare professionals. \n\n\n\nRegistration\n\n\n\nThis session will be delivered live on Zoom. Don’t miss this opportunity and register now to make sure you book your place and take part in knowledge exchange and discussions!  \n\n\n\n\nRegister for the live webinar\n\n\n\n\nLanguage\n\n\n\nThe session will be held in English with translated auto-captions into many languages (offered by Zoom platform). \n\n\n\nFind out more about the speakers:\n\n\n\nProf. Bart Van Wijmeersch\n\n\n\nChair and moderator \n\n\n\nNeurologist and Medical Director at the Rehabilitation & MS Center in Pelt\, Belgium\, and Associate Professor at Hasselt University. \n\n\n\nDr Serena Borrelli\n\n\n\nSpeaker  \n\n\n\nNeurologist and Medical Doctor at Univertsité Libre de Bruxelles\, Belgium \n\n\n\nProf. Jérôme de Sèze\n\n\n\nSpeaker  \n\n\n\nNeurologist at Strasbourg University Hospitals and Head of the MS Expert Centre / CRC SEP in France. \n\n\n\nPiet Eelen\, RN\, MSc\n\n\n\nSpeaker  \n\n\n\nClinical Nurse Specialist in Multiple Sclerosis at the National MS Center in Melsbroek\, Belgium. \n\n\n\nFunding\n\n\n\nThis webinar was organized with the financial support of Sandoz. \n\n\n\nSandoz has not been involved in the elaboration of the presentations.
URL:https://paradigms.foundation/event/live-webinar-a-biosimilar-in-multiple-sclerosis-care-in-belgium-evidence-confidence-and-implementation/
ATTACH;FMTTYPE=image/jpeg:https://paradigms.foundation/wp-content/uploads/2026/08/paradigms-foundation-webinar-biosimilars-in-belgium-002.jpg
END:VEVENT
END:VCALENDAR